OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 50 filers reported holding OMEGA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,559 | -62.2% | 201,190 | -1.5% | 0.00% | – |
| Q2 2023 | $1,144,141 | +381.9% | 204,311 | +418.9% | 0.00% | – |
| Q1 2023 | $237,413 | +12.5% | 39,372 | +6.6% | 0.00% | – |
| Q4 2022 | $210,984 | +43.5% | 36,950 | +35.9% | 0.00% | – |
| Q3 2022 | $147,000 | +93.4% | 27,184 | +36.7% | 0.00% | – |
| Q2 2022 | $76,000 | -92.8% | 19,883 | -88.2% | 0.00% | – |
| Q1 2022 | $1,055,000 | +27.9% | 168,990 | +132.1% | 0.00% | – |
| Q4 2021 | $825,000 | -34.2% | 72,794 | +9.5% | 0.00% | – |
| Q3 2021 | $1,253,000 | – | 66,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
| CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
| Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
| HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
| Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
| Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
| Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
| Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |